ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
This study has been terminated.
Information provided by:
First received: April 16, 2007
Last updated: March 19, 2008
Last verified: March 2008
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Estimated Study Completion Date:||May 2009|
|Estimated Primary Completion Date:||No date given|